Pharos Energy Valuation

Is PHAR undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of PHAR when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: PHAR (£0.23) is trading below our estimate of fair value (£0.63)

Significantly Below Fair Value: PHAR is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for PHAR?

Key metric: As PHAR is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for PHAR. This is calculated by dividing PHAR's market cap by their current revenue.
What is PHAR's PS Ratio?
PS Ratio0.9x
SalesUS$137.60m
Market CapUS$119.26m

Price to Sales Ratio vs Peers

How does PHAR's PS Ratio compare to its peers?

The above table shows the PS ratio for PHAR vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average1.2x
KIST Kistos Holdings
0.5x20.1%UK£89.1m
JSE Jadestone Energy
0.4x2.8%UK£128.7m
CASP Caspian Sunrise
2.5x-11.2%UK£76.7m
ENW Enwell Energy
1.3x-116.6%UK£50.5m
PHAR Pharos Energy
0.9x-8.0%UK£95.3m

Price-To-Sales vs Peers: PHAR is good value based on its Price-To-Sales Ratio (0.9x) compared to the peer average (1.2x).


Price to Sales Ratio vs Industry

How does PHAR's PS Ratio compare vs other companies in the GB Oil and Gas Industry?

11 CompaniesPrice / SalesEstimated GrowthMarket Cap
ROSN Rosneft Oil
0.1xn/aUS$21.03b
TLW Tullow Oil
0.3x-6.1%US$420.91m
ENQ EnQuest
0.2x-9.7%US$281.27m
NWF NWF Group
0.08x4.8%US$90.36m
PHAR 0.9xIndustry Avg. 1.4xNo. of Companies11PS01.22.43.64.86+
11 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: PHAR is good value based on its Price-To-Sales Ratio (0.9x) compared to the UK Oil and Gas industry average (1.4x).


Price to Sales Ratio vs Fair Ratio

What is PHAR's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

PHAR PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio0.9x
Fair PS Ratio0.5x

Price-To-Sales vs Fair Ratio: PHAR is expensive based on its Price-To-Sales Ratio (0.9x) compared to the estimated Fair Price-To-Sales Ratio (0.5x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst PHAR forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUK£0.23
UK£0.44
+93.1%
33.7%UK£0.60UK£0.24n/a3
Nov ’25UK£0.22
UK£0.44
+101.0%
33.7%UK£0.60UK£0.24n/a3
Oct ’25UK£0.23
UK£0.44
+93.1%
33.7%UK£0.60UK£0.24n/a3
Sep ’25UK£0.24
UK£0.38
+55.5%
34.0%UK£0.50UK£0.20n/a3
Aug ’25UK£0.26
UK£0.38
+45.4%
34.0%UK£0.50UK£0.20n/a3
Jul ’25UK£0.24
UK£0.38
+58.6%
34.4%UK£0.50UK£0.20n/a3
Jun ’25UK£0.23
UK£0.38
+69.1%
34.4%UK£0.50UK£0.20n/a3
May ’25UK£0.23
UK£0.38
+65.8%
34.2%UK£0.50UK£0.20n/a3
Apr ’25UK£0.21
UK£0.38
+82.6%
34.2%UK£0.50UK£0.20n/a3
Mar ’25UK£0.20
UK£0.39
+97.0%
34.4%UK£0.50UK£0.20n/a3
Feb ’25UK£0.21
UK£0.40
+89.9%
28.5%UK£0.50UK£0.24n/a3
Jan ’25UK£0.21
UK£0.43
+101.0%
24.8%UK£0.55UK£0.29n/a3
Dec ’24UK£0.22
UK£0.44
+99.5%
24.5%UK£0.56UK£0.30n/a3
Nov ’24UK£0.23
UK£0.44
+95.1%
24.5%UK£0.56UK£0.30UK£0.223
Oct ’24UK£0.23
UK£0.38
+65.5%
34.5%UK£0.55UK£0.24UK£0.234
Sep ’24UK£0.23
UK£0.38
+67.1%
35.2%UK£0.56UK£0.24UK£0.244
Aug ’24UK£0.23
UK£0.37
+62.3%
35.2%UK£0.55UK£0.23UK£0.264
Jul ’24UK£0.22
UK£0.38
+72.3%
33.1%UK£0.55UK£0.24UK£0.244
Jun ’24UK£0.23
UK£0.38
+70.6%
32.0%UK£0.55UK£0.24UK£0.234
May ’24UK£0.23
UK£0.38
+65.2%
31.8%UK£0.54UK£0.24UK£0.234
Apr ’24UK£0.22
UK£0.39
+73.1%
31.4%UK£0.55UK£0.25UK£0.214
Mar ’24UK£0.26
UK£0.39
+53.6%
31.1%UK£0.56UK£0.25UK£0.204
Feb ’24UK£0.23
UK£0.38
+63.9%
32.1%UK£0.55UK£0.24UK£0.214
Jan ’24UK£0.23
UK£0.48
+105.7%
38.2%UK£0.71UK£0.25UK£0.214
Dec ’23UK£0.25
UK£0.48
+90.2%
38.2%UK£0.71UK£0.25UK£0.224
Nov ’23UK£0.26
UK£0.48
+82.9%
38.2%UK£0.71UK£0.25UK£0.234

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.


Discover undervalued companies